Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Am J Physiol Cell Physiol ; 284(6): C1397-404, 2003 Jun.
Article in English | MEDLINE | ID: mdl-12584113

ABSTRACT

Neurotensin (NT), a neuropeptide highly expressed in the gastrointestinal tract, participates in the pathophysiology of intestinal inflammation. We recently showed that NT stimulates interleukin-8 (IL-8) expression in NCM460 nontransformed human colonic epithelial cells via both mitogen-activating protein kinase (MAPK)- and NF-kappaB-dependent pathways. However, the molecular mechanism by which NT induces expression of proinflammatory cytokines such as IL-8 has not been investigated. In this study we show that inhibition of endogenous Rho family proteins (RhoA, Rac1, and Cdc42) by their respective dominant negative mutants inhibits NT-induced IL-8 protein production and promoter activity. Western blot experiments demonstrated that NT strongly activated RhoA, Rac1, and Cdc42. Overexpression of the dominant negative mutants of RhoA, Rac1, and Cdc42 significantly inhibited NT-induced NF-kappaB-dependent reporter gene expression and NF-kappaB DNA binding activity. NT also stimulated p38 MAPK phosphorylation, and overexpression of dominant negative mutants of RhoA, Rac1, and Cdc42 did not significantly alter p38 and ERK1/2 phosphorylation in response to NT. Together, our findings indicate that NT-stimulated IL-8 expression is mediated via a Rho-dependent NF-kappaB-mediated pathway.


Subject(s)
Epithelial Cells/metabolism , Interleukin-8/metabolism , NF-kappa B/metabolism , Neurotensin/metabolism , cdc42 GTP-Binding Protein/metabolism , rac1 GTP-Binding Protein/metabolism , rhoA GTP-Binding Protein/metabolism , Cell Line , Colon/anatomy & histology , Colon/metabolism , Enzyme Activation , Epithelial Cells/cytology , Gene Expression Regulation , Genes, Reporter , Humans , Interleukin-8/genetics , Mitogen-Activated Protein Kinases/metabolism , Serum Response Element , Signal Transduction/physiology , cdc42 GTP-Binding Protein/genetics , p38 Mitogen-Activated Protein Kinases , rac1 GTP-Binding Protein/genetics , rhoA GTP-Binding Protein/genetics
2.
Biochem J ; 368(Pt 2): 665-72, 2002 Dec 01.
Article in English | MEDLINE | ID: mdl-12169092

ABSTRACT

Interaction of the neuropeptide substance P (SP) and its neurokinin-1 receptor (NK-1R) plays an important role in the pathophysiology of intestinal inflammation. SP is known to stimulate production of interleukin (IL)-6 and IL-8 in the U-373-MG human astrocytoma cell line via activation of p38 MAPK (mitogen-activated protein kinase) and nuclear factor (NF)-kappaB, respectively. However, the signalling mechanisms by which SP-NK-1R interaction induces NF-kappaB activation and IL-8 expression are still not clear. In this study we demonstrate that SP stimulates IL-8 secretion and IL-8 promoter activity in the NCM460 non-transformed human colonic epithelial cell line transfected with NK-1R cDNA. Our results indicate that inhibition of endogenous Rho family proteins (RhoA, Rac1 and Cdc42) by their respective dominant negative mutants significantly decreases SP-induced IL-8 secretion and IL-8 promoter activity. We also demonstrate that SP rapidly activates RhoA, Rac1 and Cdc42 and that co-expression of the dominant negative mutants of RhoA, Rac1 and Cdc42 in NK-1R cDNA-transfected NCM460 cells significantly inhibits SP-induced NF-kappaB-dependent gene expression. These results demonstrate that Rho family small GTPases RhoA, Rac1 and Cdc42 are novel signal transducers for SP-stimulated IL-8 expression.


Subject(s)
Colon/metabolism , Interleukin-8/metabolism , Substance P/pharmacology , rhoA GTP-Binding Protein/metabolism , Cells, Cultured , Colon/cytology , Colon/drug effects , Epithelial Cells/drug effects , Epithelial Cells/metabolism , Genes, Dominant , Humans , Interleukin-8/genetics , NF-kappa B/drug effects , NF-kappa B/genetics , NF-kappa B/metabolism , Promoter Regions, Genetic , Receptors, Neurokinin-1/drug effects , Receptors, Neurokinin-1/genetics , Receptors, Neurokinin-1/metabolism , Serum Response Element/drug effects , Signal Transduction , Substance P/metabolism , cdc42 GTP-Binding Protein/drug effects , cdc42 GTP-Binding Protein/genetics , cdc42 GTP-Binding Protein/metabolism , rac1 GTP-Binding Protein/drug effects , rac1 GTP-Binding Protein/genetics , rac1 GTP-Binding Protein/metabolism , rhoA GTP-Binding Protein/drug effects , rhoA GTP-Binding Protein/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...